retatrutide diabetes type 2 Tirzepatide vs. Retatrutide: Key Differences Explained retatrutide type 2 diabetes trial
Description
BMJ Open
No excuse anymore
As of December 2025, Medicare does not cover GLP-1s for weight loss, and several state Medicaid programs rolled back coverage in 2025
When used alongside diet and exercise, it can help them achieve healthy and sustainable weight loss
As more people look for natural ways to support appetite, energy and metabolic balance there is increasing interest in nutrients that help the body's own GLP-1 response function optimally
Starting GLP-1 therapy only to stop it two months before trying to conceive may not provide a long enough treatment window to achieve meaningful results
